Page 34 - Read Online

filling of pectus excavatum or other malformations of the 4. Requena L, Requena C, Christensen L, Zimmermann US, Kutzner H, Cerroni
skeleton. Complications secondary to this filler include L. Adverse reactions to injectable soft tissue fillers. J Am Acad Dermatol
edema, bruising, nodules, and infections, but no granulomas 5. 2011;64:1-34.
Christensen L, Breiting V, Janssen M, Vuust J, Hogdall E. Adverse reactions to
have been described. Histopathologically, this filler appears injectable soft tissue permanent fillers. Aesthetic Plast Surg 2005;29:34-48.
as basophilic amorphous material with granular appearance 6. De Boulle K. Management of complications after implantation of fillers. J
surrounded by sparse numbers of epithelioid histiocytes, 7. Cosmet Dermatol 2004;3:2-15.
Bertossi D, Sbarbati A, Cerini R, Barillari M, Favero V, Picozzi V, Ruzzenente O,
foreign body multinucleated giant cells, neutrophils, and Salvagno G, Guidi GC, Nocini P. Hyaluronic acid: in vitro and in vivo analysis,
red cells. [106-110] biochemical properties and histological and morphological evaluation of
injected filler. Eur J Dermatol 2013;23:449-55.
Polyvinylhdydroxide microspheres 8. Wang F, Garza LA, Kang S, Varani J, Orringer JS, Fisher GJ, Voorhees JJ. In
vivo stimulation of a de novo collagen production caused by cross-linked
suspended in polyacrylamide gel hyaluronic acid dermal filler injections in photodamaged human skin. Arch
This is a permanent filler composed of composed of a Dermatol 2007;143:155-63.
suspension of 6 polyvinylhydroxide microspheres suspended 9. Turlier V, Delalleau A, Casas C, Rouquier A, Bianchi P, Alvarez S, Josse G,
Briant A, Dahan S, Saint-Martory C, Theunis J, Bensafi-Benaouda A, Degouy
in 2.5% polyacrylamide gel (Evolution; ProCytech SA), A, Schmitt AM, Redoulès D. Association between collagen production
and has been used mostly for lip augmentation. This is a and mechanical stretching in dermal extracellular matrix: in vivo effect of
rarely used filler, and there are not descriptions of adverse cross-linked hyaluronic acid filler. A randomised, placebo-controlled study. J
Dermatol Sci 2013;69:187-94.
reactions to this filler, other that the observation made by 10. Watson W, Kaye RL, Klein A, Stegman S. Collagen: a clinical overview. Cutis
Lemperle et al. who, in their comparative paper on fillers, 1983;31:543-6.
[49]
injected Evolution (and later excised it from the first author’s 11. Klein AW, Rish DC. Dermatology: bovine injectable collagen. West J Med
forearm) and found the filler to give little local reaction and 1985;143:231.
diminish slowly over 9 months. [4] 12. Knapp TR, Kaplan EN, Daniels JR. Injectable collagen for soft tissue
augmentation. Plast Reconstr Surg 1977;60:389-405.
13. Stegman SJ, Chu S, Bensch K, Amstrong R. A light and electron microscopic
CONCLUSION evaluation of Zyderm collagen and Zyplast implants in aging human facial
skin: a pilot study. Arch Dermatol 1987;123:1644-9.
14. Douglas RS, Donsoff I, Cook T, Shorr N. Collagen fillers in facial aesthetic
Although dermal fillers have been used for decades in surgery. Facial Plast Surg 2004;20:117-23.
aesthetic medicine, the ideal filler is still missing, because all 15. Mullins RJ, Richards C, Walker T. Allergic reaction to oral, surgical and
of them known today may cause adverse reactions. Patients’ topical bovine collagen. Anaphylactic risk for surgeons. Aust N Z J Ophthalmol
1996;24:257-60.
safety is hampered by nonlicensed products and users. 16. Siegle RJ, McCoy JP, Schade W, Swanson NA. Intradermal implantation
These side effects are tend to be less severe after injection of bovine collagen. humoral immune responses associated with clinical
with non-permanent or semi-permanant biodegradable skin reactions. Arch Dermatol 1984;120:183-7.
fillers, which will mostly disappear spontaneously within a 17. Sclafani A, Romo T, Jacono AA, McCormick SA, Cocker R,Parker A. Evaluation
few months. Unfortunately, however, after injection with of acellular dermal graft in sheet (Alloderm) and injectable (micronized
Alloderm) forms for soft tissue augmentation: clinical observations and
slowly or nonbiodegradable permanant fillers, sever adverse histologic findings. Arch Facial Plast Surg 2000;2:130-6.
reactions may appear and need active treatment. Follow-up 18. Fagien S. Facial soft-tissue augmentation with injectable autologous and
of patients by trained physicians is necessary to reduce risks allogenic human tissue collagen matrix (autologen and dermalogen). Plast
Reconstr Surg 2000;105:362-73.
and initiate early treatment in case of complications. Careful 19. Moody BR, Sengelmann RD. Self-limited adverse reaction to human-derived
selection of patients and particular selection of products, collagen injectable product. Dermatol Surg 2000;26:936-8.
matching particular needs, and skilled injector is the best way 20. Wise JB, Greco T. Injectable treatments for the aging face. Facial Plast Surg
to perform safe three-dimensional rejuvenation and achieve 2006;22:140-6.
high patient’s satisfaction. In the future, individualized, 21. Lupo MP. Hyaluronic acid fillers in facial rejuvenation. Semin Cutan Med Surg
2006;25:122-6.
specifically tailored filler with long-lasting effect but with 22. Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K,
fewer complications might become available. Freudenberg M, Galanos C, Simon JC. Oligosaccharides of hyaluronan
activate dendritic cells via toll-like receptor 4. J Exp Med 2002;195:99-111.
23. Mansouri Y, Goldenberg G. Update on hyaluronic acid fillers for facial
Financial support and sponsorship rejuvenation. Cutis 2015;96:85-8.
Nil. 24. Turlier V, Delalleau A, Casas C, Rouquier A, Bianchi P, Alvarez S, Josse G,
Briant A, Dahan S, Saint-Martory C, Theunis J, Bensafi-Benaouda A, Degouy
Conflicts of interest A, Schmitt AM, Redoulès D. Association between collagen production
and mechanical stretching in dermal extracellular matrix: in vivo effect of
There are no conflicts of interest. cross-linked hyaluronic acid filler. A randomised, placebo-controlled study. J
Dermatol Sci 2013;69:187-94.
REFERENCES 25. Quan T, Wang F, Shao Y, Rittié L, Xia W, Orringer JS, Voorhees JJ, Fisher GJ.
Enhancing structural support of the dermal microenvironment activates
fibroblasts, endothelial cells, and keratinocytes in aged human skin in vivo. J
1. Pak CS, Lee J, Lee H, Jeong J, Kim EH, Jeong J, Choi H, Kim B, Oh S, Kim I, Heo Invest Dermatol 2013;133:658-67.
CY. A phase III, randomized, double-blind, matched-pairs, active-controlled 26. Duranti F, Salti G, Bovani B, Calandra M, Rosati ML. Injectable hyaluronic acid
clinical trial and preclinical animal study to compare the durability, efficacy gel for soft tissue augmentation. A clinical and histological study. Dermatol
and safety between polynucleotide filler and hyaluronic acid filler in the Surg 1998;24:1317-25.
correction of crow's feet: a new concept of regenerative filler. J Korean Med 27. Narins RS, Brandt F, Leyden J, Lorenc ZP, Rubin M, Smith S. A randomized,
Sci 2014;29 Suppl 3:S201-9. double-blind, multicenter comparison of the efficacy and tolerability of
2. 2014 Complete Plastic Surgery Statistic Report. Ameircan Society of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg
Plastic Surgeons. Available from: http://www.plasticsurgery.org/news/plastic- 2003;29:588-95.
surgery-statistics/2014-plastic-surgery-statistics.html. 28. Palm MD. Filler frontier: what's new and heading West to the US market.
3. Carruthers J, Carruthers A, Humphrey S. Introduction to fillers. Plast Reconstr Semin Cutan Med Surg 2014;33:157-63.
Surg 2015;136 Suppl 5:S120-31. 29. Brandt FS, Cazzaniga A. Hyaluronic acid gel fillers in the management of facial
Plast Aesthet Res || Vol 3 || Mar 23, 2016 97